A detailed history of Cheviot Value Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cheviot Value Management, LLC holds 14,600 shares of ABT stock, worth $1.69 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
14,600
Previous 15,108 3.36%
Holding current value
$1.69 Million
Previous $1.57 Million 6.05%
% of portfolio
0.34%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $50,835 - $60,010
-508 Reduced 3.36%
14,600 $1.66 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $9,569 - $10,681
-95 Reduced 0.62%
15,108 $1.57 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $78,306 - $86,486
-715 Reduced 4.49%
15,203 $1.73 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $45,095 - $55,200
-500 Reduced 3.05%
15,918 $1.75 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $143,103 - $171,700
-1,498 Reduced 8.36%
16,418 $1.59 Million
Q2 2023

Nov 07, 2023

SELL
$100.78 - $112.29 $27,512 - $30,655
-273 Reduced 1.5%
17,916 $1.95 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $24,699 - $29,072
-255 Reduced 1.38%
18,189 $1.84 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $1.19 Million - $1.4 Million
-12,532 Reduced 40.46%
18,444 $2.03 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $91,341 - $105,756
-944 Reduced 2.96%
30,976 $3 Million
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $53,892 - $65,139
-528 Reduced 1.63%
31,920 $3.47 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $327,351 - $399,183
-2,871 Reduced 8.13%
32,448 $3.84 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $102,012 - $124,909
-883 Reduced 2.44%
35,319 $4.97 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $111,293 - $123,123
-954 Reduced 2.57%
36,202 $4.28 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $296,529 - $349,057
-2,803 Reduced 7.01%
37,156 $4.31 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $44,189 - $52,061
-406 Reduced 1.01%
39,959 $4.79 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $9,660 - $10,526
-92 Reduced 0.23%
40,365 $4.42 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $15,670 - $19,030
-171 Reduced 0.42%
40,457 $4.4 Million
Q2 2020

Aug 17, 2020

SELL
$76.57 - $98.0 $53,369 - $68,306
-697 Reduced 1.69%
40,628 $3.72 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $78,525 - $114,825
-1,250 Reduced 2.94%
41,325 $3.26 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $91,385 - $101,733
-1,164 Reduced 2.66%
42,575 $3.7 Million
Q3 2019

Nov 15, 2019

SELL
$81.84 - $88.74 $18,741 - $20,321
-229 Reduced 0.52%
43,739 $3.66 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $9,620 - $11,220
-132 Reduced 0.3%
43,968 $3.7 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $75,689 - $91,508
-1,143 Reduced 2.53%
44,100 $3.53 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $321,244 - $363,923
-4,900 Reduced 9.77%
45,243 $3.27 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $125,511 - $151,415
-2,064 Reduced 3.95%
50,143 $3.68 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $378,004 - $417,203
-6,566 Reduced 11.17%
52,207 $3.18 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $87,724 - $99,183
-1,559 Reduced 2.58%
58,773 $3.52 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $24,639 - $26,378
-459 Reduced 0.76%
60,332 $3.44 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $19,512 - $21,777
406 Added 0.67%
60,791 $3.24 Million
Q2 2017

Aug 11, 2017

BUY
N/A
60,385
60,385 $2.94 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cheviot Value Management, LLC Portfolio

Follow Cheviot Value Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.